Key facts
- Anthony A. Florence Jr. has 18 issuer positions tracked on this page.
- Estimated disclosed ownership value: $364,249,628.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Anthony A. Florence Jr.
- Location
- New York, NY
- Summary
- The estimated net worth of Anthony A. Florence Jr. is at least $364,249,628 dollars as of 12 Mar 2026. Anthony A. Florence Jr. is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146.15M. Anthony A. Florence Jr. is the 10%+ Owner of Savara Inc and owns shares of Savara Inc (SVRA) stock worth about $108.9M. Anthony A. Florence Jr. is the 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $38.64M. Anthony A. Florence Jr. is the 10%+ Owner of SpyGlass Pharma, Inc. and owns shares of SpyGlass Pharma, Inc. (SGP) stock worth about $37.77M. Anthony A. Florence Jr. is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $16.81M. Anthony A. Florence Jr. is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $14.42M. Anthony A. Florence Jr. is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M. Anthony A. Florence Jr. is the 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $328.9K. Anthony A. Florence Jr. is the 10%+ Owner of IonQ, Inc. and owns shares of IonQ, Inc. (IONQ) stock worth about $13.8K. Anthony A. Florence Jr. is the 10%+ Owner of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $5.3K. Anthony A. Florence Jr. is the 10%+ Owner of Desktop Metal, Inc. and owns shares of Desktop Metal, Inc. stock worth about $591.
- Signature
- /s/ Zachary Bambach, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Anthony A. Florence Jr. and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: Monte Rosa Therapeutics, Inc. ($146,153,662).
- Past-year value change for that position: .
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Anthony A. Florence Jr.
GLUE
Forms 3/4/5
Monte Rosa Therapeutics, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $146,153,662
- Past year net change
- Change %
- Report period
- 28 Jun 2021
SVRA
Forms 3/4/5
Savara Inc
- Relationship
- 10%+ Owner
- Holdings value
- $108,897,125
- Past year net change
- Change %
- Report period
- 17 Jul 2023
MBX
Forms 3/4/5
MBX Biosciences, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $38,638,855
- Past year net change
- Change %
- Report period
- 16 Sep 2024
SGP
Forms 3/4/5
SpyGlass Pharma, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $37,772,629
- Past year net change
- Change %
- Report period
- 09 Feb 2026
TRVI
Forms 3/4/5
Trevi Therapeutics, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $16,814,393
- Past year net change
- Change %
- Report period
- 31 Dec 2025
KRRO
Forms 3/4/5
Korro Bio, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $14,419,591
- Past year net change
- +$2,300,881
- Change %
- +19%
- Report period
- 10 Mar 2026
MTCR
Forms 3/4/5
Metacrine, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $1,204,731
- Past year net change
- Change %
- Report period
- 10 Dec 2021
MIRM
Forms 3/4/5
Mirum Pharmaceuticals, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $328,907
- Past year net change
- Change %
- Report period
- 13 Jun 2023
IONQ, IONQ-WT
Forms 3/4/5
IonQ, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $13,834
- Past year net change
- Change %
- Report period
- 16 Nov 2022
AVEO
Forms 3/4/5
AVEO PHARMACEUTICALS, INC.
- Relationship
- 10%+ Owner
- Holdings value
- $5,310
- Past year net change
- Change %
- Report period
- 19 Oct 2022
DM
Forms 3/4/5
Desktop Metal, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- $591
- Past year net change
- Change %
- Report period
- 08 Jun 2021
NEUE
Forms 3/4/5
NeueHealth, Inc.
- Relationship
- Director, 10%+ Owner
- Holdings value
- $0
- Past year net change
- -$28,316
- Change %
- -100%
- Report period
- 02 Oct 2025
AKUS
Forms 3/4/5
Akouos, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- Past year net change
- Change %
- Report period
- 30 Nov 2022
ACLX
Forms 3/4/5
Arcellx, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- Past year net change
- Change %
- Report period
- 20 Dec 2022
CSPR
Forms 3/4/5
Casper Sleep Inc.
- Relationship
- Director, 10%+ Owner
- Holdings value
- Past year net change
- Change %
- Report period
- 25 Jan 2022
EAR
Forms 3/4/5
Eargo, Inc.
- Relationship
- 10%+ Owner
- Holdings value
- Past year net change
- Change %
- Report period
- 24 May 2021
GNCA
Forms 3/4/5
GENOCEA BIOSCIENCES, INC.
- Relationship
- 10%+ Owner
- Holdings value
- Past year net change
- Change %
- Report period
- 24 May 2022
HOOD
Forms 3/4/5
Robinhood Markets, Inc.
- Relationship
- Director
- Holdings value
- Past year net change
- Change %
- Report period
- 02 May 2022
Insider Transactions Reported by Anthony A. Florence Jr.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.